Jindalai (688057.SH) plans to increase capital by 280 million yuan to invest in Jici Medical.

Smart Finance APP News, Jindalai (688057.SH) announced that the company is optimistic about the development prospects of national strategic emerging industries such as research and application of stem cell technology. The company plans to gradually optimize its industrial structure to seek new business opportunities for future development, in order to improve the company's risk resistance ability and cultivate new profit growth points. The company plans to use its own funds of 280 million yuan to increase its capital to Yunnan Jici Medical Technology Co., Ltd. (referred to as "Jici Medical"). After the transaction is completed, the company will hold 34% equity of Jici Medical.